NCT07740603尚未招募不适用
Aberrant Expression of CD56 on CD38 Positive Neutrophils as a Novel Diagnostic Tool in Chronic Myeloid Leukemia
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 200
- 主要终点
- an increased change in cd 38 and cd 56 in chronic leukemic patients
研究概览
简要总结
Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.
The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •patients with chronic myeloid leukemia
排除标准
- •other hematological diseases
研究组 & 干预措施
chronic myeloid leukemia group
干预措施: cd 38 and cd 56 (Diagnostic Test)
healthy group
结局指标
主要结局
an increased change in cd 38 and cd 56 in chronic leukemic patients
时间窗: 6 months
次要结局
未报告次要终点
研究者
Mennatallah Mostafa Zaki
Resident
Sohag University
相似试验
尚未招募
不适用
Studying How Many CML Patients remain Healthy One Year After Stopping Imatinib TreatmentCTRI/2024/11/077421ACTREC, Tata Memorial Centre4
尚未招募
不适用
Understanding Childhood CML: Insights on Stopping vs. Continuing Imatinib TreatmentCTRI/2024/09/073667Tata Memorial Hospital50
尚未招募
不适用
Identifying which immune cells are present in blood cancers and how many of each type there are.CTRI/2026/01/102270MAULANA AZAD MEDICAL COLLEGE40
尚未招募
2/3 期
Optimizing Chronic Myeloid Leukemia Treatment: A Randomized Phase II Trial of Upfront Low-Dose Nilotinib in the Indian ContextCTRI/2024/03/064707All India Institute Of Medical Sciences Institute Grant146
招募中
不适用
Cohort of Patients With Chronic Myelomonocytic LeukemiaMyelomonocytic Leukemia, ChronicLeukemiaNCT07512882Gustave Roussy, Cancer Campus, Grand Paris5,000